Efficient nonviral gene therapy with FasL and Del1 fragments in mice.

about

Long-term gene therapy with Del1 fragment using nonviral vectors in mice with explanted tumors.

P2860

Q36543877-3ABB341A-86DC-4CA1-8C5F-DB0CB5B5C626

P2860

Efficient nonviral gene therapy with FasL and Del1 fragments in mice.

Item

http://www.wikidata.org/entity/Q39247938

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Efficient nonviral gene therapy with FasL and Del1 fragments in mice.

@en

Efficient nonviral gene therapy with FasL and Del1 fragments in mice.

@nl

type

Item

label

Efficient nonviral gene therapy with FasL and Del1 fragments in mice.

@en

Efficient nonviral gene therapy with FasL and Del1 fragments in mice.

@nl

prefLabel

Efficient nonviral gene therapy with FasL and Del1 fragments in mice.

@en

Efficient nonviral gene therapy with FasL and Del1 fragments in mice.

@nl

P1476

Efficient nonviral gene therapy with FasL and Del1 fragments in mice.

@en

P2093

Atsushi Mamiya

http://www.w3.org/2001/XMLSchema#string

Chiaki Hidai

http://www.w3.org/2001/XMLSchema#string

Hisataka Kitano

http://www.w3.org/2001/XMLSchema#string

Shinichiro Kokubun

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and characterization of developmental endothelial locus-1: an embryonic endothelial cell protein that binds the alphavbeta3 integrin receptor

Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence.

Rescuing the failing heart by targeted gene transfer

Progress and problems with the use of viral vectors for gene therapy.

The Del1 deposition domain can immobilize 3alpha-hydroxysteroid dehydrogenase in the extracellular matrix without interfering with enzymatic activity

An epidermal growth factor-like repeat of Del1 protein increases the efficiency of gene transfer in vitro.

Discoidin domain of Del1 protein contributes to its deposition in the extracellular matrix.

FasL gene therapy: a new therapeutic modality for head and neck cancer.

Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expression.

Antitumor effect of allogenic fibroblasts engineered to express Fas ligand (FasL).

P304

642-650

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JGM.2682

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23136083

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

Efficient nonviral gene therapy with FasL and Del1 fragments in mice.

about

P2860

P2860

Efficient nonviral gene therapy with FasL and Del1 fragments in mice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921